Namsa, which is backed by Archimed, has acquired Labcorp’s US-based early development medical testing business. No financial ...
NAMSA, a global leader in medical device testing, clinical research, and regulatory consulting, is pleased to announce it has completed the acquisition of the Early Development medical device testing ...
BURLINGTON – Life science giant LabCorp is setting aside the first hour of business at its nearly 2,000 patient service centers for the non-COVID-19 testing of seniors and what the company calls its ...
Laboratory Corporation of America Holdings LH, or LabCorp, recently started to operate at its larger anatomic pathology and histology (APH) laboratory in Los Angeles, CA. This newly developed ...
LH's growth bets in specialty testing and acquisitions support its outlook, but macro pressures and currency headwinds remain ...
US-based diagnostic testing specialist Laboratory Corporation of America Holdings (LabCorp) is tapping into a global network of central laboratories, as well as support tools for clinical trial ...
LabCorp agreed to acquire Pathology Associates Medical Laboratories from Providence Health & Services and Catholic Health Initiatives for an undisclosed amount. “This signature transaction strengthens ...
Buzz about LabCorp’s secret intention to take over INC Research had just started to quiet down when the life sciences company announced a deal—a settled one—to acquire lab assets from Mount Sinai ...
Mark Brown witnessed the birth of modern diagnostic testing from the back seat of his mother's station wagon. He just doesn't remember it, because he was a newborn himself. Mark’s father, Paul Brown, ...
BURLINGTON, N.C.--(BUSINESS WIRE)--Laboratory Corporation of America® Holdings (LabCorp®) (NYSE: LH) and Tandem Labs, a leading bioanalytical and immunoanalytical contract research organization (CRO) ...
Laboratory Corporation of America Holdings just inked a major deal with two west coast providers. The lab giant is in a deals race with rival Quest Diagnostics. Burlington, N.C.-based LabCorp ...
For my initial coverage of Labcorp, I'm calling it a hold, and an opportunity to earn a $0.72/share quarterly dividend on the leading clinical lab company in the US. The firm shows future growth ...